1. Elevated serum miR-106b and miR-146a in patients with focal and generalized epilepsy
    Ning An et al, 2016, Epilepsy Research CrossRef
  2. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades
    Philip Alexandrovich Koshkin et al, 2014, Clinica Chimica Acta CrossRef
  3. Apigenin inhibits growth of melanoma by suppressing miR-512-3p and promoting the G1 phase of cell cycle involving the p27 Kip1 protein
    Qun Xie et al, 2022, Molecular and Cellular Biochemistry CrossRef
  4. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein
    Ram Prasad et al, 2014, Oncotarget CrossRef
  5. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis
    YIFAN LI et al, 2016, Molecular Medicine Reports CrossRef
  6. Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells
    Jiajia Chen et al, 2016, Frontiers in Cellular Neuroscience CrossRef
  7. Expression of microRNAs in tumors of the central nervous system in pediatric patients in México
    Pilar Eguía-Aguilar et al, 2017, Child's Nervous System CrossRef
  8. CircPCMTD1 Acts as the Sponge of miR-224-5p to Promote Glioma Progression
    Si-Qi Zheng et al, 2019, Frontiers in Oncology CrossRef
  9. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight
    Ruth Ruiz Esparza-Garrido et al, 2013, Journal of Proteomics CrossRef
  10. The Therapeutic Role of MicroRNAs in Human Gliomas
    Sanila H. Sarkar et al, 2014, MicroRNA Targeted Cancer Therapy CrossRef
  11. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes
    F Liu et al, 2014, Oncogene CrossRef
  12. Current Insights into Signature MicroRNA Networks and Signal Transduction in Osteosarcoma
    Jash Trivedi et al, 2024, Current Pharmacology Reports CrossRef